4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-26-075069
Chief Financial Officer sold 73,360 shares at $4.51 ($330,744)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gabay Avraham Chief Financial Officer | 2026-07-01 | Sale | −73,360 | $4.51 | $330,744 | 671,785 | D |
| Open-market sales · 73,360 sh · avg $4.51 · $330,744 | |||||||
Loading xslF345X06/ownership.xml…